Docusign (NASDAQ:DOCU) Now Covered by Analysts at UBS Group

Docusign logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • UBS initiated coverage of Docusign with a Neutral rating and an $85 price target, implying 12.98% upside from the prior close.
  • Analyst views are mostly cautious: 15 rate the stock Hold, three Buy, and one Sell; MarketBeat cites an average price target of $69.50.
  • Docusign’s latest quarterly results beat estimates, with EPS of $1.16 versus $1.09 expected and revenue of $875.75 million versus $867.22 million expected; revenue rose 9.4% year over year.
  • MarketBeat previews top five stocks to own in December.

UBS Group started coverage on shares of Docusign (NASDAQ:DOCU - Get Free Report) in a report issued on Thursday, Benzinga reports. The brokerage set a "neutral" rating and a $85.00 price target on the stock. UBS Group's price objective suggests a potential upside of 12.98% from the stock's previous close.

A number of other brokerages have also recently commented on DOCU. BTIG Research raised their price objective on shares of Docusign from $75.00 to $90.00 and gave the stock a "buy" rating in a research note on Wednesday. Morgan Stanley boosted their price objective on Docusign from $69.00 to $75.00 and gave the stock an "equal weight" rating in a research note on Friday, September 4th. Bank of America raised their price target on shares of Docusign from $58.00 to $64.00 and gave the stock an "underperform" rating in a research note on Friday, September 4th. Wells Fargo & Company raised their target price on Docusign from $55.00 to $60.00 and gave the stock an "equal weight" rating in a research note on Friday, September 4th. Finally, Wall Street Zen lowered Docusign from a "strong-buy" rating to a "buy" rating in a research report on Sunday, August 2nd. Three investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average price target of $69.50.

Read Our Latest Stock Analysis on Docusign

Docusign Stock Performance

Shares of DOCU stock traded down $1.34 during mid-day trading on Thursday, reaching $75.23. 1,030,201 shares of the company's stock traded hands, compared to its average volume of 3,797,247. The firm has a market capitalization of $14.06 billion, a PE ratio of 45.98, a price-to-earnings-growth ratio of 2.79 and a beta of 0.80. Docusign has a 12 month low of $40.16 and a 12 month high of $85.90. The firm has a 50 day moving average price of $74.70 and a two-hundred day moving average price of $56.14.

Docusign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings data on Thursday, September 3rd. The company reported $1.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.09 by $0.07. The business had revenue of $875.75 million for the quarter, compared to the consensus estimate of $867.22 million. Docusign had a return on equity of 18.29% and a net margin of 9.82%. The company's quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.30 earnings per share. As a group, equities analysts expect that Docusign will post 2.15 earnings per share for the current fiscal year.

Insider Activity

In other Docusign news, Director Mary Wilderotter sold 1,000 shares of the business's stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $68.80, for a total transaction of $68,800.00. Following the completion of the transaction, the director owned 2,199 shares in the company, valued at approximately $151,291.20. The trade was a 31.26% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider James P. Shaughnessy sold 12,000 shares of Docusign stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $68.80, for a total transaction of $825,600.00. Following the completion of the transaction, the insider directly owned 50,591 shares in the company, valued at $3,480,660.80. This represents a 19.17% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 154,168 shares of company stock worth $10,491,896. Insiders own 0.59% of the company's stock.

Institutional Investors Weigh In On Docusign

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. John Boyer Inc. acquired a new position in Docusign in the third quarter worth $26,000. V Square Quantitative Management LLC bought a new position in shares of Docusign during the 3rd quarter worth approximately $27,000. Pinnacle Wealth Planning Services Inc. increased its position in shares of Docusign by 78.5% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 607 shares of the company's stock valued at $41,000 after acquiring an additional 267 shares during the last quarter. Virtus Advisers LLC bought a new position in shares of Docusign in the 2nd quarter valued at about $47,000. Finally, Rakuten Securities Inc. bought a new position in Docusign during the second quarter worth $49,000. 77.64% of the stock is currently owned by institutional investors and hedge funds.

About Docusign

(Get Free Report)

DocuSign, Inc. provides software for preparing, signing, managing and automating agreements. Its platform helps businesses and individuals complete agreements digitally, reducing reliance on paper-based processes. The company's offerings include DocuSign eSignature, which enables users to sign and request signatures electronically, as well as tools for contract lifecycle management and agreement workflows. Its Intelligent Agreement Management products use artificial intelligence to help organizations analyze and manage agreement-related information and processes.

Read More

Analyst Recommendations for Docusign (NASDAQ:DOCU)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines